Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Kintor Pharma Announces the Primary Endpoint of Phase II Clinical Study for KX-826's Treatment of Androgenetic Alopecia Was Met 2021-09-08 22:13
Huadong Medicine and Insilico Medicine enter co-development partnership to advance oncology drug discovery by hitting undruggable targets 2021-09-08 20:08
The Valens Company Achieves Access to GMP Manufacturing in Australia & Expands International Footprint to Asia-Pacific through Exclusive Partnership with Epsilon Healthcare 2021-09-08 19:00
Yiling Pharmaceutical's Yishen Yangxin Anshen Tablets Granted Drug Certificate 2021-09-08 12:28
Adlai Nortye Announces First Patient Dosed in Phase Ia Clinical Trial of AN2025 and AN0025 in Combination with atezolizumab for Advanced Solid Tumors 2021-09-08 11:04
Innovent Announces First Patient with Type 2 Diabetes Dosed in a Phase 2 Clinical Trial of IBI362 (a GLP-1R and Glucagon Receptor Dual Agonist) in China 2021-09-08 08:00
Brii Biosciences Adds US$100 Million to Advance its Late-Stage Monoclonal Antibody Combination Therapy, BRII-196/BRII-198, for Non-Hospitalized COVID-19 Patients 2021-09-07 19:04
RedHill Biopharma's Opaganib Demonstrates Significant Decrease of Kidney Fibrosis 2021-09-07 19:00
RedHill Biopharma Presents Three New Analyses of Movantik Data at PAINWeek 2021 2021-09-07 18:00
Jubilant Biosys Limited announces the appointment of Mr. Giuliano Perfetti as Chief Executive Officer 2021-09-07 16:11
JW Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection in China 2021-09-06 19:03
GenScript ProBio Enters into Agreement with SYNIMMUNE for Manufacturing of their Innovative Antibody Drug 2021-09-06 16:00
Peijia Medical Engages Professor Saibal Kar as Exclusive Consultant 2021-09-06 13:44
Kintor Pharma Included in Hong Kong Stock Connect Program 2021-09-06 11:30
CStone Pharmaceuticals Included in the Hong Kong Stock Connect 2021-09-06 11:30
GeneQuantum and BrighGene sign agreement for development of antibody immune agonist conjugates 2021-09-06 09:00
AffaMed Therapeutics Enters into Strategic Partnership Agreement with Beijing Tiantan Hospital and Infinite Brain Technologies to Promote Digital Therapy in Neurological Diseases 2021-09-06 08:00
WuXi AppTec Receives AA ESG Rating from MSCI 2021-09-06 08:00
PharmAbcine Receives HREC Clearance for Phase II Trial of Olinvacimab and Pembrolizumab in mTNBC 2021-09-03 20:00
Insilico Medicine Appoints the Former Chief Medical Officer of Schering Plough, Dr. Robert Spiegel, MD, FACP, as acting Chief Medical Officer (CMO) to Oversee the Clinical Translation of its Preclinical Pipeline Assets 2021-09-02 21:00
1 225 226 227 228 229 413